0001564590-17-012607.txt : 20170615 0001564590-17-012607.hdr.sgml : 20170615 20170615163025 ACCESSION NUMBER: 0001564590-17-012607 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170614 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20170615 DATE AS OF CHANGE: 20170615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27598 FILM NUMBER: 17913826 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 8-K 1 irix-8k_20170614.htm 8-K irix-8k_20170614.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

June 14, 2017

 

 

IRIDEX CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

0-27598

 

77-0210467

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

1212 Terra Bella Avenue

Mountain View, California 94043

(Address of principal executive offices, including zip code)

 

(650) 940-4700

(Registrants telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 



 

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders of IRIDEX Corporation (IRIDEX or the Company) held on June 14, 2017 (the Annual Meeting), the stockholders of IRIDEX re-elected the following individuals to the Board of Directors. Each Director will serve for the ensuing year or until their respective successors are duly elected and qualified.

 

 

 

 

 

 

Nominee

Votes For

Votes Against

Abstentions

Broker Non Votes*

William M. Moore

5,690,433

405,413

1,000

2,884,491

Sanford Fitch

5,583,192

404,945

108,709

2,884,491

Ruediger Naumann-Etienne

5,769,711

214,426

112,709

2,884,491

George Marcellino

5,965,394

18,743

112,709

2,884,491

* Broker non-votes do not affect the outcome of the election.

In addition, the following proposals were voted on and approved at the Annual Meeting.

 

 

 

 

 

 

Proposal

Votes For

Votes Against

Abstentions

Broker Non Votes

Proposal to ratify the appointment of BPM LLP as the independent registered public accountants of the Company for the fiscal year ending December 30, 2017

8,980,777

560

-

-

Proposal to approve, on a non-binding advisory basis, the compensation of the Companys named executive officers as described in the proxy statement

5,675,832

26,378

394,636

2,884,4914

Proposal to approve the amended and restated 2008 Equity Incentive Plan

5,980,009

 

110,340

 

6,497

 

2,884,491

 



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

IRIDEX CORPORATION

 

 

 

 

By:

/s/ WILLIAM M. MOORE

 

 

William M. Moore

President and Chief Executive Officer

 

Date: June 15, 2017